Augmentation of antidepressants with atypical antipsychotics: a review of the current literature

Journal of Psychiatric Practice
Noah S PhilipLawrence H Price

Abstract

Studies have found that a large percentage of depressed patients may have limited response and remission rates when treated with traditional antidepressants. Options for augmenting antidepressant treatment include buspirone, lithium, and triiodothyronine. There are also increasing data concerning the use of atypical antipsychotics as augmenting agents in the treatment of unipolar, nonpsychotic, treatment-resistant depression. Aripiprazole has recently received an indication from the U.S. Food and Drug Administration (FDA) for adjunctive treatment in unipolar, nonpsychotic depression, the first indication of its kind, after two double-blind trials; doses were slightly lower than those recommended for monotherapy in schizophrenia or bipolar disorder. Olanzapine and risperidone have several controlled clinical trials indicating the efficacy of both of these agents, generally at low doses. One trial of quetiapine suggested that it may not be effective in the treatment of unipolar, nonpsychotic depression. One open-label trial of ziprasidone indicated some efficacy. According to these results, aripiprazole, olanzapine, and risperidone are reasonable choices as augmentation agents, with only aripiprazole currently having an FDA indic...Continue Reading

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Mar 1, 1992·Social Psychiatry and Psychiatric Epidemiology·A C LeonG L Klerman
May 1, 1986·Psychiatry Research·A J RushC Burns
Sep 1, 1982·Journal of Affective Disorders·M M Robertson, M R Trimble
Mar 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·B J CarrollJ F Greden
Dec 1, 1993·Journal of Clinical Psychopharmacology·D BakishA Blanchard
Apr 30, 1999·The Journal of Clinical Psychiatry·R B Ostroff, J C Nelson
Jan 4, 2001·The American Journal of Psychiatry·R C SheltonH Y Meltzer
Mar 21, 2001·Bipolar Disorders·S N GhaemiF K Goodwin
Aug 29, 2002·The Journal of Clinical Psychiatry·Shigehiro Hirose, Charles R Ashby
Apr 23, 2003·Biological Psychiatry·Maurizio Fava
Apr 23, 2003·Biological Psychiatry·Anthony J Rothschild
Apr 23, 2003·Biological Psychiatry·A John RushSanjay Dubé
Jul 2, 2003·Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation·Y Chawla, Deepak Amrapurkar
Aug 26, 2003·The Journal of Clinical Psychiatry·Mark B Detweiler, David B Trinkle
Jan 1, 1959·The British Journal of Medical Psychology·M HAMILTON
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Dec 9, 2003·The Journal of Clinical Psychiatry·Sara A CoryaSanjay Dubé
Jan 21, 2004·The International Journal of Neuropsychopharmacology·Kunihiko TaniNorio Mori
Mar 9, 2004·The Journal of Clinical Psychiatry·George I PapakostasMaurizio Fava
Dec 14, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·David J Hellerstein
Feb 11, 2005·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·James G BarbeeNowal J Jamhour
Aug 10, 2005·Psychiatric Services : a Journal of the American Psychiatric Association·Marcelo P Fleck, Ewald Horwath
Sep 30, 2005·Journal of Child and Adolescent Psychopharmacology·Sanjeev PathakRobert A Kowatch
Jun 7, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Audrey R TyrkaLinda L Carpenter
Jun 9, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mark Hyman RapaportCharles B Nemeroff
Sep 13, 2006·The Journal of Clinical Psychiatry·John W Newcomer
Oct 12, 2007·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·George S AlexopoulosCharles Reynolds
Nov 3, 2007·Annals of Internal Medicine·Ramy A MahmoudGeorges M Gharabawi-Garibaldi

❮ Previous
Next ❯

Citations

Nov 26, 2010·Psychopharmacology·Gregory V Carr, Irwin Lucki
May 28, 2013·CNS Drugs·Chi-Un Pae, Ashwin A Patkar
Jul 30, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Xiaohua Li, Richard S Jope
Jun 2, 2012·Patient Preference and Adherence·Khalid Saad Al-Harbi
Aug 1, 2012·Journal of Pregnancy·Sandeep RahaAlison C Holloway
Aug 28, 2010·Expert Opinion on Investigational Drugs·Arun V RavindranGebrehiwot Abraham
Oct 3, 2013·Expert Opinion on Investigational Drugs·Kuan-Pin SuChi-Un Pae
Jul 4, 2009·Expert Opinion on Drug Metabolism & Toxicology·Harriët M Loovers, Jan van der Weide
Feb 9, 2011·Psychosomatics·Sarah M MarkowitzSteven A Safren
May 27, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Giuseppe TringaliPierluigi Navarra
Jul 20, 2010·Research in Gerontological Nursing·Carlos H Rojas-FernandezCheryl A Sadowski
Apr 23, 2013·Acta Psychiatrica Scandinavica. Supplementum·G S MalhiK Fritz
Feb 27, 2010·The International Journal of Eating Disorders·Mary Ellen TrunkoWalter H Kaye
Aug 6, 2014·European Journal of Pharmacology·Olivia F O'LearyJohn F Cryan
Apr 15, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Antita AdriaensKathelijne Peremans
Dec 9, 2015·The Australian and New Zealand Journal of Psychiatry·Gin S MalhiAjeet B Singh
Jul 16, 2010·Journal of Clinical Psychopharmacology·Christina L Rim, Michael J Gitlin
Nov 18, 2008·Journal of Clinical Psychopharmacology·Brett Y LuWilliam J Apfeldorf
Jan 22, 2010·CNS Drugs·Richard C SheltonSara A Corya
May 28, 2010·The British Journal of Psychiatry. Supplement·D A W Johnson
Feb 16, 2010·Expert Opinion on Pharmacotherapy·Noah S PhilipLawrence H Price
May 14, 2020·The International Journal of Neuropsychopharmacology·Rachael W TaylorAnthony J Cleare
Sep 16, 2008·CNS Drugs·Juliane WeberLesley J Scott
Nov 10, 2020·Focus : Journal of Life Long Learning in Psychiatry·Zachary A CordnerJ Raymond DePaulo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here